{{Rsnum
|rsid=2245218
|Gene=PRDM2
|Chromosome=1
|position=13813331
|Orientation=minus
|GMAF=0.1685
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PRDM2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.4 | 23.1 | 1.5
| HCB | 60.0 | 35.6 | 4.4
| JPT | 38.6 | 52.3 | 9.1
| YRI | 93.7 | 6.3 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 60.0 | 35.6 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}rs2245218 increases susceptibility to Parkinson's disease 1.67 times for carriers of the G allele {{PMID|16252231|OA=1
}}

{{PMID|16685661|OA=1
}} Genomewide association, Parkinson disease, and PARK10.

{{PMID|16685662|OA=1
}} No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

{{PMID|16685663|OA=1
}} A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}